13 multiple-sequence-alignment Postdoctoral research jobs at University of Maryland, Baltimore
Sort by
Refine Your Search
-
Post-Doctoral Position - Pulse Sequence and Reconstruction Techniques for Prospective Motion Correction y - (250000N6) The Center for Advanced Imaging Research (CAIR) within the Department
-
, Center for Advanced Microbiome Research and Innovation (CAMRI) within the Institute for Genome Sciences (IGS) is recruiting multiple postdoctoral fellows to join our interdisciplinary team studying
-
in bioinformatics, molecular microbiology, and/or microbial ecology/evolution to apply. Qualifications Key areas: * Metagenomic and metatranscriptomic sequencing analysis * Single-cell RNA-seq and
-
activity affects cell physiology and cancer transformation. We adopt innovative sequencing technologies (RNA-Seq, ChIP-Seq, ATAC-Seq, and more) to the bulk and single-cell samples from patient samples
-
areas: · Metagenomic and metatranscriptomic sequencing analysis · Single-cell RNA-seq and proteomic/metabolomic data integration · Integration of clinical and multi-omic microbiome data
-
molecular biology, demonstrated by first authorship in a peer-reviewed publication. While expertise in nucleic acid sequencing, biostatistics, cell culture, and animal handling is advantageous, it is not
-
building hosting many interdisciplinary research teams, including the Institute of Genome Sciences. The salary will be aligned with NIH and UMB pay scales. Application Process: To apply, please submit
-
extraction and TLC analysis, immunoprecipitation and protein purification, ChIP assays, and/or sample preparations for single cell or nucleus RNA sequencing. To apply for this position, please send your CV
-
including RNA, DNA, and extracellular vesicles isolations, QPCR, western blot, microarrays, and RNA sequencing is expected. Experience with flow cytometry is preferred. Experience in the analysis of genomics
-
, we investigate the role of enhancers in transcription control, and how changes in enhancer activity affects cell physiology and cancer transformation. We adopt innovative sequencing technologies (RNA